Litcius/Paper detail

Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes – randomized controlled trial

Henrik Maagensen, Julie Rask Larsen, Niklas Rye Jørgensen, Anders Fink‐Jensen, Tina Vilsbøll

2020Psychiatry Research16 citationsDOI

Topics & Concepts

LiraglutideInternal medicineMedicineEndocrinologyPrediabetesOlanzapineBone remodelingN-terminal telopeptideClozapinePlaceboSchizophrenia (object-oriented programming)Type 2 diabetesDiabetes mellitusPsychiatryOsteocalcinBiologyAlternative medicineEnzymePathologyBiochemistryAlkaline phosphataseDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiet and metabolism studies
Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes – randomized controlled trial | Litcius